Patent intelligence · US
US 10525290
Compositions for forming films having a desired degree of obscuration and methods of making and using the same
Compositions for forming films having a desired degree of obscuration and methods of making and using the same
Patent details — US 10525290
- Jurisdiction
- US
- Status
- granted
- Grant date
- Jan 7, 2020
- Expiration
- Jan 2, 2040
- Applicant
- W.R. Grace & Co.-Conn.
- Claims
- 19
- CPC classes
- A61K, A61K8/25, A61K8/31, A61K8/8129
Quick answer
US 10525290 (Compositions for forming films having a desired degree of obscuration and methods of making and using the same) is held by W.R. Grace & Co.-Conn.. Status: granted. Granted Jan 7, 2020. Expires Jan 2, 2040 (13 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- W.R. Grace & Co.-Conn.
- Grant date
- Expiration
- Claims
- 19
- CPC classes
- A61K, A61K8/25, A61K8/31, A61K8/8129, A61K8/891, A61K8/894
More from W.R. Grace & Co.-Conn.
Related pharmaceutical patents in our USPTO index.
-
US 12414943
Nimodipine parenteral administration
granted -
US 12049487
Universal chimeric antigen receptor T-cell preparation technique
granted -
US 11840575
Engineered immune cells targeting BCMA and their uses thereof
granted -
US 11484501
Mechanochemical activated dry amorphisation by milling equilibrium between ap mesoporous silica
granted -
US 11478424
Mechanochemcial activated dry amorphisation by milling equilibrium between AP mesoporous silica
granted -
US 11478420
Vaginal probiotic products and related processes
granted -
US 11291672
Betamethasone oral spray formulation and method of use to treat ataxia
granted -
US 11052029
Cation compatible metal oxides and oral care compositions containing the metal oxides
granted
Frequently asked questions
What is US patent 10525290?
US 10525290 (Compositions for forming films having a desired degree of obscuration and methods of making and using the same) is held by W.R. Grace & Co.-Conn.. Status: granted. Granted Jan 7, 2020. Expires Jan 2, 2040 (13 years remaining) — relevant for patent-cliff and LOE planning.
Who owns US 10525290?
W.R. Grace & Co.-Conn. is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 34 pharmaceutical patents for this assignee.
When does US 10525290 expire?
Our index shows an expiration date of Jan 2, 2040 (13 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.